ADAP · Categories · Form 3

ADAP - SEC Form 3 initial insider statements

Adaptimmune Therapeutics plc (ADAP) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for ADAP

• 245d
  SEC Form 3 filed by new insider Hill Christopher James

  3 - Adaptimmune Therapeutics PLC (0001621227) (Issuer)
• 807d
  New insider Ecor1 Capital, Llc claimed ownership of 164,424,420 units of Ordinary Shares (SEC Form 3)

  3 - Adaptimmune Therapeutics PLC (0001621227) (Issuer)
• 952d
  SEC Form 3 filed by new insider Hege Kristen

  3 - Adaptimmune Therapeutics PLC (0001621227) (Issuer)
• 1105d
  SEC Form 3 filed by new insider Menzel Garry E

  3 - Adaptimmune Therapeutics PLC (0001621227) (Issuer)
• 1105d
  SEC Form 3 filed by new insider Hegde Priti

  3 - Adaptimmune Therapeutics PLC (0001621227) (Issuer)
• 1105d
  SEC Form 3 filed by new insider Allen Andrew R

  3 - Adaptimmune Therapeutics PLC (0001621227) (Issuer)
• 1498d
  SEC Form 3 filed by new insider Brewer Joanna Elizabeth

  3 - Adaptimmune Therapeutics PLC (0001621227) (Issuer)
• 1591d
  SEC Form 3 filed by new insider Piccina Cintia

  3 - Adaptimmune Therapeutics PLC (0001621227) (Issuer)

Other ADAP categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends